Integrated F-Fluorodeoxyglucose–Positron Emission Tomography/Dynamic Contrast-Enhanced Computed Tomography to Phenotype Non–Small Cell Lung Carcinoma
We applied modern molecular and functional imaging to the pretreatment assessment of lung cancer using combined dynamic contrast-enhanced computed tomography (DCE-CT) and 18 F-fluorodeoxyglucose–positron emission tomography ( 18 F-FDG-PET) to phenotype tumors. Seventy-four lung cancer patients were...
Main Authors: | Manu Shastry, Kenneth A. Miles, Thida Win, Sam M. Janes, Raymond Endozo, Marie Meagher, Peter J. Ell, Ashley M. Groves |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi - SAGE Publishing
2012-09-01
|
Series: | Molecular Imaging |
Online Access: | https://doi.org/10.2310/7290.2011.00052 |
Similar Items
-
Bilateral Diffuse Fluorodeoxyglucose Uptake in Thyroid Gland Diagnosed by Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography
by: Aung Zaw Win, et al.
Published: (2014-01-01) -
Role of fluorodeoxyglucose positron emission tomography-Computed tomography in thyroid malignancy
by: Ajay Manickam, et al.
Published: (2017-01-01) -
Novel Positron Emission Tomography/Computed Tomography of Diffuse Parenchymal Lung Disease Combining a Labeled Somatostatin Receptor Analogue and 2-Deoxy-2 [F] Fluoro-D-Glucose
by: Thida Win, et al.
Published: (2012-03-01) -
Role of Positron Emission Tomography with Fluorodeoxyglucose in Prostate Cancer
by: Yiyan Liu
Published: (2013-09-01) -
Hepatic Pseudolymphoma with Fluorodeoxyglucose Uptake on Positron Emission Tomography
by: Kazuhiro Suzumura, et al.
Published: (2017-12-01)